Which adverse effect is documented for evinacumab?

Enhance your knowledge of antihyperlipidemics and lipid management. Study with multiple choice questions and detailed explanations. Ace your test!

Multiple Choice

Which adverse effect is documented for evinacumab?

Biologic therapies can trigger immune-mediated hypersensitivity, and evinacumab is no exception. Evinacumab is a monoclonal antibody given by IV infusion, and a documented safety concern with this class is the possibility of severe hypersensitivity reactions, including anaphylaxis. Because of this risk, patients are monitored during infusion and clinicians are prepared to treat any reaction promptly with emergency measures (eg, epinephrine, airway support, fluids). While milder or more nonspecific adverse effects like nasal symptoms or dizziness can occur with various medications, and infusion-related discomfort might be considered, the serious and documented risk for this drug is hypersensitivity reactions. This makes severe hypersensitivity the most clinically significant and specifically documented adverse effect to watch for with evinacumab.

Biologic therapies can trigger immune-mediated hypersensitivity, and evinacumab is no exception. Evinacumab is a monoclonal antibody given by IV infusion, and a documented safety concern with this class is the possibility of severe hypersensitivity reactions, including anaphylaxis. Because of this risk, patients are monitored during infusion and clinicians are prepared to treat any reaction promptly with emergency measures (eg, epinephrine, airway support, fluids).

While milder or more nonspecific adverse effects like nasal symptoms or dizziness can occur with various medications, and infusion-related discomfort might be considered, the serious and documented risk for this drug is hypersensitivity reactions. This makes severe hypersensitivity the most clinically significant and specifically documented adverse effect to watch for with evinacumab.

More practice questions